2XNY - JenaLib

Asymmetric Unit (31, 62)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_033930	Y	140	H	FIBG_HUMAN	Polymorphism	2066870	C/F	Y	114	H
02	UniProt	VAR_002399	R	160	S	FIBA_HUMAN	Unclassified	---	A/D	R	141	S
03	UniProt	VAR_014170	G	191	R	FIBG_HUMAN	Polymorphism	6063	C/F	G	165	R
04	UniProt	VAR_072723	C	184	W	FIBA_HUMAN	Disease (CAFBN)	---	A/D	C	165	W
05	UniProt	VAR_016908	R	196	C	FIBB_HUMAN	Disease (CAFBN)	121909623	B/E	R	166	C
06	UniProt	VAR_072620	L	202	Q	FIBB_HUMAN	Disease (CAFBN)	121909624	B/E	L	172	Q
07	UniProt	VAR_013093	P	265	L	FIBB_HUMAN	Polymorphism	6054	B/E	P	235	L
08	UniProt	VAR_002409	R	301	C	FIBG_HUMAN	Polymorphism	121913087	C/F	R	275	C
09	UniProt	VAR_002410	R	301	H	FIBG_HUMAN	Disease (DYSFIBRIN)	121913088	C/F	R	275	H
10	UniProt	VAR_072726	T	303	P	FIBG_HUMAN	Disease (CAFBN)	---	C/F	T	277	P
11	UniProt	VAR_002411	G	318	V	FIBG_HUMAN	Disease (DYSFIBRIN)	121913089	C/F	G	292	V
12	UniProt	VAR_072727	D	327	H	FIBG_HUMAN	Disease (CAFBN)	---	C/F	D	301	H
13	UniProt	VAR_002413	N	334	I	FIBG_HUMAN	Polymorphism	121913090	C/F	N	308	I
14	UniProt	VAR_002412	N	334	K	FIBG_HUMAN	Unclassified	---	C/F	N	308	K
15	UniProt	VAR_015853	G	335	D	FIBG_HUMAN	Unclassified	---	C/F	G	309	D
16	UniProt	VAR_002414	M	336	T	FIBG_HUMAN	Polymorphism	121913091	C/F	M	310	T
17	UniProt	VAR_072728	N	345	D	FIBG_HUMAN	Disease (CAFBN)	---	C/F	N	319	D
18	UniProt	VAR_002416	Q	355	R	FIBG_HUMAN	Polymorphism	121913092	C/F	Q	329	R
19	UniProt	VAR_002418	D	356	V	FIBG_HUMAN	Disease (DYSFIBRIN)	121913094	C/F	D	330	V
20	UniProt	VAR_002417	D	356	Y	FIBG_HUMAN	Polymorphism	121913093	C/F	D	330	Y
21	UniProt	VAR_002407	A	365	T	FIBB_HUMAN	Polymorphism	121909617	B/E	A	335	T
22	UniProt	VAR_002419	N	363	K	FIBG_HUMAN	Unclassified	---	C/F	N	337	K
23	UniProt	VAR_016909	L	383	R	FIBB_HUMAN	Disease (CAFBN)	121909621	B/E	L	353	R
24	UniProt	VAR_002421	S	384	C	FIBG_HUMAN	Unclassified	---	C/F	S	358	C
25	UniProt	VAR_002422	R	401	G	FIBG_HUMAN	Polymorphism	75848804	C/F	R	375	G
26	UniProt	VAR_072729	R	401	W	FIBG_HUMAN	Disease (CAFBN)	75848804	C/F	R	375	W
27	UniProt	VAR_072725	T	407	K	FIBB_HUMAN	Disease (CAFBN)	---	B/E	T	377	K
28	UniProt	VAR_072621	S	404	P	FIBG_HUMAN	Disease (DYSFIBRIN)	587777720	C/F	S	378	P
29	UniProt	VAR_014171	M	410	V	FIBG_HUMAN	Polymorphism	6061	C/F	M	384	V
30	UniProt	VAR_016910	G	430	D	FIBB_HUMAN	Disease (CAFBN)	121909622	B/E	G	400	D
31	UniProt	VAR_002408	R	478	K	FIBB_HUMAN	Polymorphism	4220	B/E	R	448	K

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (31, 31)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_033930	Y	140	H	FIBG_HUMAN	Polymorphism	2066870	C	Y	114	H
02	UniProt	VAR_002399	R	160	S	FIBA_HUMAN	Unclassified	---	A	R	141	S
03	UniProt	VAR_014170	G	191	R	FIBG_HUMAN	Polymorphism	6063	C	G	165	R
04	UniProt	VAR_072723	C	184	W	FIBA_HUMAN	Disease (CAFBN)	---	A	C	165	W
05	UniProt	VAR_016908	R	196	C	FIBB_HUMAN	Disease (CAFBN)	121909623	B	R	166	C
06	UniProt	VAR_072620	L	202	Q	FIBB_HUMAN	Disease (CAFBN)	121909624	B	L	172	Q
07	UniProt	VAR_013093	P	265	L	FIBB_HUMAN	Polymorphism	6054	B	P	235	L
08	UniProt	VAR_002409	R	301	C	FIBG_HUMAN	Polymorphism	121913087	C	R	275	C
09	UniProt	VAR_002410	R	301	H	FIBG_HUMAN	Disease (DYSFIBRIN)	121913088	C	R	275	H
10	UniProt	VAR_072726	T	303	P	FIBG_HUMAN	Disease (CAFBN)	---	C	T	277	P
11	UniProt	VAR_002411	G	318	V	FIBG_HUMAN	Disease (DYSFIBRIN)	121913089	C	G	292	V
12	UniProt	VAR_072727	D	327	H	FIBG_HUMAN	Disease (CAFBN)	---	C	D	301	H
13	UniProt	VAR_002413	N	334	I	FIBG_HUMAN	Polymorphism	121913090	C	N	308	I
14	UniProt	VAR_002412	N	334	K	FIBG_HUMAN	Unclassified	---	C	N	308	K
15	UniProt	VAR_015853	G	335	D	FIBG_HUMAN	Unclassified	---	C	G	309	D
16	UniProt	VAR_002414	M	336	T	FIBG_HUMAN	Polymorphism	121913091	C	M	310	T
17	UniProt	VAR_072728	N	345	D	FIBG_HUMAN	Disease (CAFBN)	---	C	N	319	D
18	UniProt	VAR_002416	Q	355	R	FIBG_HUMAN	Polymorphism	121913092	C	Q	329	R
19	UniProt	VAR_002418	D	356	V	FIBG_HUMAN	Disease (DYSFIBRIN)	121913094	C	D	330	V
20	UniProt	VAR_002417	D	356	Y	FIBG_HUMAN	Polymorphism	121913093	C	D	330	Y
21	UniProt	VAR_002407	A	365	T	FIBB_HUMAN	Polymorphism	121909617	B	A	335	T
22	UniProt	VAR_002419	N	363	K	FIBG_HUMAN	Unclassified	---	C	N	337	K
23	UniProt	VAR_016909	L	383	R	FIBB_HUMAN	Disease (CAFBN)	121909621	B	L	353	R
24	UniProt	VAR_002421	S	384	C	FIBG_HUMAN	Unclassified	---	C	S	358	C
25	UniProt	VAR_002422	R	401	G	FIBG_HUMAN	Polymorphism	75848804	C	R	375	G
26	UniProt	VAR_072729	R	401	W	FIBG_HUMAN	Disease (CAFBN)	75848804	C	R	375	W
27	UniProt	VAR_072725	T	407	K	FIBB_HUMAN	Disease (CAFBN)	---	B	T	377	K
28	UniProt	VAR_072621	S	404	P	FIBG_HUMAN	Disease (DYSFIBRIN)	587777720	C	S	378	P
29	UniProt	VAR_014171	M	410	V	FIBG_HUMAN	Polymorphism	6061	C	M	384	V
30	UniProt	VAR_016910	G	430	D	FIBB_HUMAN	Disease (CAFBN)	121909622	B	G	400	D
31	UniProt	VAR_002408	R	478	K	FIBB_HUMAN	Polymorphism	4220	B	R	448	K

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (31, 31)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_033930	Y	140	H	FIBG_HUMAN	Polymorphism	2066870	F	Y	114	H
02	UniProt	VAR_002399	R	160	S	FIBA_HUMAN	Unclassified	---	D	R	141	S
03	UniProt	VAR_014170	G	191	R	FIBG_HUMAN	Polymorphism	6063	F	G	165	R
04	UniProt	VAR_072723	C	184	W	FIBA_HUMAN	Disease (CAFBN)	---	D	C	165	W
05	UniProt	VAR_016908	R	196	C	FIBB_HUMAN	Disease (CAFBN)	121909623	E	R	166	C
06	UniProt	VAR_072620	L	202	Q	FIBB_HUMAN	Disease (CAFBN)	121909624	E	L	172	Q
07	UniProt	VAR_013093	P	265	L	FIBB_HUMAN	Polymorphism	6054	E	P	235	L
08	UniProt	VAR_002409	R	301	C	FIBG_HUMAN	Polymorphism	121913087	F	R	275	C
09	UniProt	VAR_002410	R	301	H	FIBG_HUMAN	Disease (DYSFIBRIN)	121913088	F	R	275	H
10	UniProt	VAR_072726	T	303	P	FIBG_HUMAN	Disease (CAFBN)	---	F	T	277	P
11	UniProt	VAR_002411	G	318	V	FIBG_HUMAN	Disease (DYSFIBRIN)	121913089	F	G	292	V
12	UniProt	VAR_072727	D	327	H	FIBG_HUMAN	Disease (CAFBN)	---	F	D	301	H
13	UniProt	VAR_002413	N	334	I	FIBG_HUMAN	Polymorphism	121913090	F	N	308	I
14	UniProt	VAR_002412	N	334	K	FIBG_HUMAN	Unclassified	---	F	N	308	K
15	UniProt	VAR_015853	G	335	D	FIBG_HUMAN	Unclassified	---	F	G	309	D
16	UniProt	VAR_002414	M	336	T	FIBG_HUMAN	Polymorphism	121913091	F	M	310	T
17	UniProt	VAR_072728	N	345	D	FIBG_HUMAN	Disease (CAFBN)	---	F	N	319	D
18	UniProt	VAR_002416	Q	355	R	FIBG_HUMAN	Polymorphism	121913092	F	Q	329	R
19	UniProt	VAR_002418	D	356	V	FIBG_HUMAN	Disease (DYSFIBRIN)	121913094	F	D	330	V
20	UniProt	VAR_002417	D	356	Y	FIBG_HUMAN	Polymorphism	121913093	F	D	330	Y
21	UniProt	VAR_002407	A	365	T	FIBB_HUMAN	Polymorphism	121909617	E	A	335	T
22	UniProt	VAR_002419	N	363	K	FIBG_HUMAN	Unclassified	---	F	N	337	K
23	UniProt	VAR_016909	L	383	R	FIBB_HUMAN	Disease (CAFBN)	121909621	E	L	353	R
24	UniProt	VAR_002421	S	384	C	FIBG_HUMAN	Unclassified	---	F	S	358	C
25	UniProt	VAR_002422	R	401	G	FIBG_HUMAN	Polymorphism	75848804	F	R	375	G
26	UniProt	VAR_072729	R	401	W	FIBG_HUMAN	Disease (CAFBN)	75848804	F	R	375	W
27	UniProt	VAR_072725	T	407	K	FIBB_HUMAN	Disease (CAFBN)	---	E	T	377	K
28	UniProt	VAR_072621	S	404	P	FIBG_HUMAN	Disease (DYSFIBRIN)	587777720	F	S	378	P
29	UniProt	VAR_014171	M	410	V	FIBG_HUMAN	Polymorphism	6061	F	M	384	V
30	UniProt	VAR_016910	G	430	D	FIBB_HUMAN	Disease (CAFBN)	121909622	E	G	400	D
31	UniProt	VAR_002408	R	478	K	FIBB_HUMAN	Polymorphism	4220	E	R	448	K

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 3 (0, 0)

						dbSNP	PDB
No.	Source	Variant ID	Variant	UniProt ID	Status	ID	Chain	Variant

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (2, 8)

Exons (13, 26)

Sequences/Alignments

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:57
 aligned with FIBA_HUMAN | P02671 from UniProtKB/Swiss-Prot  Length:866

    Alignment length:57
                                   162       172       182       192       202       
           FIBA_HUMAN   153 QLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIA 209
               SCOP domains --------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------- Pfam domains
         Sec.struct. author .....hhhhhhhhhhhhhhhhhhhhhh.............hhhhhhhhhhh...... Sec.struct. author
                 SAPs(SNPs) -------S-----------------------W------------------------- SAPs(SNPs)
                    PROSITE --------------------------------------------------------- PROSITE
               Transcript 1 Exon 1.4b         Exon 1.5b  PDB: A:152-190 [INCOMPLETE]  Transcript 1
                 2xny A 134 QLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIA 190
                                   143       153       163       173       183

Chain B from PDB  Type:PROTEIN  Length:298
 aligned with FIBB_HUMAN | P02675 from UniProtKB/Swiss-Prot  Length:491

    Alignment length:298
                                   200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480        
           FIBB_HUMAN   191 IPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 488
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....hhhhhhhhhhhhhhhhhhhhhhhhhhhh....ee...ee.....hhhhhhhh.....eeeee........eeeeee.......eeeeeee.........hhhhhhhhee..ee.........ee..ee.hhhhhhhhhh...eeeeeeee.....eeeeeeeeeee.hhhhh..eeeeeeee...hhhhhh.....hhhhhh..........................................ee........................eehhhhh......eeeeeeee.. Sec.struct. author
                 SAPs(SNPs) -----C-----Q--------------------------------------------------------------L---------------------------------------------------------------------------------------------------T-----------------R-----------------------K----------------------D-----------------------------------------------K---------- SAPs(SNPs)
                PROSITE (2) -----------------------------------------FIBRINOGEN_C_2  PDB: B:202-458 UniProt: 232-488                                                                                                                                                                                                                   PROSITE (2)
                PROSITE (1) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_-------------------------------------------- PROSITE (1)
           Transcript 2 (1) Exon 2.4b  PDB: B:161-210 UniProt: 164-240        -------------------------------------Exon 2.6  PDB: B:248-290 UniProt: 278-320  ----------------------------------------------------------------------------------------------Exon 2.8c  PDB: B:385-458 UniProt: 415-491 [INCOMPLETE]                    Transcript 2 (1)
           Transcript 2 (2) -------------------------------------------------Exon 2.5  PDB: B:210-248               -----------------------------------------Exon 2.7  PDB: B:290-385 UniProt: 320-415                                                       ------------------------------------------------------------------------- Transcript 2 (2)
                 2xny B 161 IPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 458
                                   170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450

Chain C from PDB  Type:PROTEIN  Length:288
 aligned with FIBG_HUMAN | P02679 from UniProtKB/Swiss-Prot  Length:453

    Alignment length:288
                                   140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410        
           FIBG_HUMAN   131 SSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRL 418
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ......hhhhhhhhhhhhhhhhhhhhhhh......ee..........hhhhhhhh.....eeeee........eeeeeee.....eeeeeeee.........hhhhhhhheeee.......ee.hhhhhhhhhh.....eeeeeeee.....eeeeeee..ee.hhhhh..ee..eeee....hhhhh.......hhhhhh...................hhhhhhh..........ee...........hhhhh........ee...........eeeeeeee.hhh Sec.struct. author
             SAPs(SNPs) (1) ---------H--------------------------------------------------R-------------------------------------------------------------------------------------------------------------C-P--------------V--------H------IDT--------D---------RV------K--------------------C----------------G--P-----V-------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------H--------------------------------K---------------------Y--------------------------------------------W----------------- SAPs(SNPs) (2)
                PROSITE (1) ---------------------------------------FIBRINOGEN_C_2  PDB: C:144-390 UniProt: 170-416                                                                                                                                                                                                        -- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ PROSITE (2)
                PROSITE (3) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_---------------------------------------------- PROSITE (3)
           Transcript 3 (1) 3.2g-------------------------------------------Exon 3.3f  PDB: C:152-196 UniProt: 178-222   Exon 3.4b  PDB: C:197-258 UniProt: 223-284                    --------------------------------------------------------------------------------------------Exon 3.6c  PDB: C:351-392 UniProt: 377-453 Transcript 3 (1)
           Transcript 3 (2) ---Exon 3.3a  PDB: C:108-152 UniProt: 134-178   ---------------------------------------------------------------------------------------------------------Exon 3.5  PDB: C:258-351 UniProt: 284-377                                                     ----------------------------------------- Transcript 3 (2)
                 2xny C 105 SSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRL 392
                                   114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384

Chain D from PDB  Type:PROTEIN  Length:57
 aligned with FIBA_HUMAN | P02671 from UniProtKB/Swiss-Prot  Length:866

    Alignment length:57
                                   162       172       182       192       202       
           FIBA_HUMAN   153 QLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIA 209
               SCOP domains --------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------- CATH domains
           Pfam domains (1) Fib_alpha-2xnyD01 D:134-175               --------------- Pfam domains (1)
           Pfam domains (2) Fib_alpha-2xnyD02 D:134-175               --------------- Pfam domains (2)
         Sec.struct. author .....hhhhhhhhhhhhhhhhhhhhhh.............hhhhhhhhhhh...... Sec.struct. author
                 SAPs(SNPs) -------S-----------------------W------------------------- SAPs(SNPs)
                    PROSITE --------------------------------------------------------- PROSITE
               Transcript 1 Exon 1.4b         Exon 1.5b  PDB: D:152-190 [INCOMPLETE]  Transcript 1
                 2xny D 134 QLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIA 190
                                   143       153       163       173       183

Chain E from PDB  Type:PROTEIN  Length:298
 aligned with FIBB_HUMAN | P02675 from UniProtKB/Swiss-Prot  Length:491

    Alignment length:298
                                   200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480        
           FIBB_HUMAN   191 IPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 488
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) Fib_alpha-2xnyE03 E:161-205                  -Fibrinogen_C-2xnyE01 E:207-457                                                                                                                                                                                                                             - Pfam domains (1)
           Pfam domains (2) Fib_alpha-2xnyE04 E:161-205                  -Fibrinogen_C-2xnyE02 E:207-457                                                                                                                                                                                                                             - Pfam domains (2)
         Sec.struct. author .....hhhhhhhhhhhhhhhhhhhhhhhhhhhh....ee...ee.....hhhhhhhh.....eeeee........eeeeee.......eeeeeee.........hhhhhhhhee..ee.........ee..ee.hhhhhhhhhh...eeeeeeee.....eeeeeeeeeee.hhhhh..eeeeeeee...hhhhhh.....hhhhhh..........................................ee........................eehhhhh......eeeeeeee.. Sec.struct. author
                 SAPs(SNPs) -----C-----Q--------------------------------------------------------------L---------------------------------------------------------------------------------------------------T-----------------R-----------------------K----------------------D-----------------------------------------------K---------- SAPs(SNPs)
                PROSITE (2) -----------------------------------------FIBRINOGEN_C_2  PDB: E:202-458 UniProt: 232-488                                                                                                                                                                                                                   PROSITE (2)
                PROSITE (1) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_-------------------------------------------- PROSITE (1)
           Transcript 2 (1) Exon 2.4b  PDB: E:161-210 UniProt: 164-240        -------------------------------------Exon 2.6  PDB: E:248-290 UniProt: 278-320  ----------------------------------------------------------------------------------------------Exon 2.8c  PDB: E:385-458 UniProt: 415-491 [INCOMPLETE]                    Transcript 2 (1)
           Transcript 2 (2) -------------------------------------------------Exon 2.5  PDB: E:210-248               -----------------------------------------Exon 2.7  PDB: E:290-385 UniProt: 320-415                                                       ------------------------------------------------------------------------- Transcript 2 (2)
                 2xny E 161 IPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFF 458
                                   170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450

Chain F from PDB  Type:PROTEIN  Length:288
 aligned with FIBG_HUMAN | P02679 from UniProtKB/Swiss-Prot  Length:453

    Alignment length:288
                                   140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410        
           FIBG_HUMAN   131 SSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRL 418
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
           Pfam domains (1) Fib_alpha-2xnyF03 F:105-147                -Fibrinogen_C-2xnyF01 F:149-389                                                                                                                                                                                                                   --- Pfam domains (1)
           Pfam domains (2) Fib_alpha-2xnyF04 F:105-147                -Fibrinogen_C-2xnyF02 F:149-389                                                                                                                                                                                                                   --- Pfam domains (2)
         Sec.struct. author ......hhhhhhhhhhhhhhhhhhhhhhh......ee..........hhhhhhhh.....eeeee........eeeeeee.....eeeeeeee.........hhhhhhhheeee.......ee.hhhhhhhhhh.....eeeeeeee.....eeeeeee..ee.hhhhh..ee..eeee....hhhhh.......hhhhhh...................hhhhhhh..........ee...........hhhhh........ee...........eeeeeeee.hhh Sec.struct. author
             SAPs(SNPs) (1) ---------H--------------------------------------------------R-------------------------------------------------------------------------------------------------------------C-P--------------V--------H------IDT--------D---------RV------K--------------------C----------------G--P-----V-------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------H--------------------------------K---------------------Y--------------------------------------------W----------------- SAPs(SNPs) (2)
                PROSITE (1) ---------------------------------------FIBRINOGEN_C_2  PDB: F:144-390 UniProt: 170-416                                                                                                                                                                                                        -- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ PROSITE (2)
                PROSITE (3) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FIBRINOGEN_C_---------------------------------------------- PROSITE (3)
           Transcript 3 (1) 3.2g-------------------------------------------Exon 3.3f  PDB: F:152-196 UniProt: 178-222   Exon 3.4b  PDB: F:197-258 UniProt: 223-284                    --------------------------------------------------------------------------------------------Exon 3.6c  PDB: F:351-392 UniProt: 377-453 Transcript 3 (1)
           Transcript 3 (2) ---Exon 3.3a  PDB: F:108-152 UniProt: 134-178   ---------------------------------------------------------------------------------------------------------Exon 3.5  PDB: F:258-351 UniProt: 284-377                                                     ----------------------------------------- Transcript 3 (2)
                 2xny F 105 SSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRL 392
                                   114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384

Chain M from PDB  Type:PROTEIN  Length:37
                                                                     
               SCOP domains ------------------------------------- SCOP domains
               CATH domains ------------------------------------- CATH domains
               Pfam domains ------------------------------------- Pfam domains
         Sec.struct. author .......................hhhhh......... Sec.struct. author
                 SAPs(SNPs) ------------------------------------- SAPs(SNPs)
                    PROSITE ------------------------------------- PROSITE
                 Transcript ------------------------------------- Transcript
                 2xny M  96 KAKQALEDQRKDLETKLKELQQDYDLAKESTSWDRQR 132
                                   105       115       125

Chain N from PDB  Type:PROTEIN  Length:36
                                                                    
               SCOP domains ------------------------------------ SCOP domains
               CATH domains ------------------------------------ CATH domains
               Pfam domains ------------------------------------ Pfam domains
         Sec.struct. author ........hhhhhh..............hhhhh... Sec.struct. author
                 SAPs(SNPs) ------------------------------------ SAPs(SNPs)
                    PROSITE ------------------------------------ PROSITE
                 Transcript ------------------------------------ Transcript
                 2xny N 100 ALEDQRKDLETKLKELQQDYDLAKESTSWDRQRLEK 135
                                   109       119       129

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (2, 10)

Gene Ontology (65, 151)

Asymmetric Unit(hide GO term definitions)

Chain A,D (FIBA_HUMAN | P02671)

molecular function
	GO:0050839	cell adhesion molecule binding	Interacting selectively and non-covalently with a cell adhesion molecule.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0030674	protein binding, bridging	The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
	GO:0005198	structural molecule activity	The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
biological process
	GO:0006953	acute-phase response	An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
	GO:0002250	adaptive immune response	An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0072377	blood coagulation, common pathway	A protein activation cascade that contributes to blood coagulation and consists of events leading from the formation of activated factor X to the formation of active thrombin, the cleavage of fibrinogen by thrombin, and the formation of cleaved fibrin into a stable multimeric, cross-linked complex.
	GO:0072378	blood coagulation, fibrin clot formation	A protein activation cascade that contributes to blood coagulation and consists of the cascade of enzymatic reactions initiated by physical damage to the wall of a blood vessel, leading to the formation of a formation of a fibrin clot at the site of the injury. The process also includes numerous positive and negative regulatory events.
	GO:0007160	cell-matrix adhesion	The binding of a cell to the extracellular matrix via adhesion molecules.
	GO:0043623	cellular protein complex assembly	The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell.
	GO:0044267	cellular protein metabolic process	The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
	GO:0071345	cellular response to cytokine stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
	GO:1990643	cellular response to granulocyte colony-stimulating factor	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a granulocyte colony-stimulating factor stimulus.
	GO:0071354	cellular response to interleukin-6	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-6 stimulus.
	GO:0071407	cellular response to organic cyclic compound	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0030198	extracellular matrix organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
	GO:0042730	fibrinolysis	A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0002376	immune system process	Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
	GO:0043152	induction of bacterial agglutination	Any process in which infecting bacteria are clumped together by a host organism.
	GO:0045087	innate immune response	Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
	GO:0097421	liver regeneration	The regrowth of lost or destroyed liver.
	GO:2000261	negative regulation of blood coagulation, common pathway	Any process that stops, prevents or reduces the frequency, rate or extent of blood coagulation, common pathway.
	GO:2000352	negative regulation of endothelial cell apoptotic process	Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
	GO:0031639	plasminogen activation	The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.
	GO:0030168	platelet activation	A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
	GO:0070527	platelet aggregation	The adhesion of one platelet to one or more other platelets via adhesion molecules.
	GO:0002576	platelet degranulation	The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
	GO:0070374	positive regulation of ERK1 and ERK2 cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0045921	positive regulation of exocytosis	Any process that activates or increases the frequency, rate or extent of exocytosis.
	GO:0034116	positive regulation of heterotypic cell-cell adhesion	Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
	GO:0090277	positive regulation of peptide hormone secretion	Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
	GO:0050714	positive regulation of protein secretion	Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
	GO:0045907	positive regulation of vasoconstriction	Any process that activates or increases the frequency, rate or extent of vasoconstriction.
	GO:0006461	protein complex assembly	The aggregation, arrangement and bonding together of a set of components to form a protein complex.
	GO:0051258	protein polymerization	The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.
	GO:0051592	response to calcium ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
	GO:0046898	response to cycloheximide	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cycloheximide stimulus. Cycloheximide (actidione) is an antibiotic produced by some Streptomyces species which interferes with protein synthesis in eukaryotes.
	GO:0032355	response to estradiol	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
	GO:0033595	response to genistein	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a genistein stimulus.
	GO:0043278	response to morphine	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a morphine stimulus. Morphine is an opioid alkaloid, isolated from opium, with a complex ring structure.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0005938	cell cortex	The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:1903561	extracellular vesicle	Any vesicle that is part of the extracellular region.
	GO:0005577	fibrinogen complex	A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0031091	platelet alpha granule	A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
	GO:0031093	platelet alpha granule lumen	The volume enclosed by the membrane of the platelet alpha granule.
	GO:0005791	rough endoplasmic reticulum	The rough (or granular) endoplasmic reticulum (ER) has ribosomes adhering to the outer surface; the ribosomes are the site of translation of the mRNA for those proteins which are either to be retained within the cisternae (ER-resident proteins), the proteins of the lysosomes, or the proteins destined for export from the cell. Glycoproteins undergo their initial glycosylation within the cisternae.

Chain B,E (FIBB_HUMAN | P02675)

molecular function
	GO:0050839	cell adhesion molecule binding	Interacting selectively and non-covalently with a cell adhesion molecule.
	GO:0051087	chaperone binding	Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0030674	protein binding, bridging	The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
	GO:0005198	structural molecule activity	The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
biological process
	GO:0002250	adaptive immune response	An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0072378	blood coagulation, fibrin clot formation	A protein activation cascade that contributes to blood coagulation and consists of the cascade of enzymatic reactions initiated by physical damage to the wall of a blood vessel, leading to the formation of a formation of a fibrin clot at the site of the injury. The process also includes numerous positive and negative regulatory events.
	GO:0007160	cell-matrix adhesion	The binding of a cell to the extracellular matrix via adhesion molecules.
	GO:0043623	cellular protein complex assembly	The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell.
	GO:0071347	cellular response to interleukin-1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
	GO:0044320	cellular response to leptin stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism.
	GO:0030198	extracellular matrix organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
	GO:0042730	fibrinolysis	A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0002376	immune system process	Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
	GO:0043152	induction of bacterial agglutination	Any process in which infecting bacteria are clumped together by a host organism.
	GO:0045087	innate immune response	Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
	GO:2000352	negative regulation of endothelial cell apoptotic process	Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
	GO:0031639	plasminogen activation	The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.
	GO:0030168	platelet activation	A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
	GO:0070527	platelet aggregation	The adhesion of one platelet to one or more other platelets via adhesion molecules.
	GO:0002576	platelet degranulation	The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
	GO:0070374	positive regulation of ERK1 and ERK2 cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0045921	positive regulation of exocytosis	Any process that activates or increases the frequency, rate or extent of exocytosis.
	GO:0034116	positive regulation of heterotypic cell-cell adhesion	Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
	GO:0090277	positive regulation of peptide hormone secretion	Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
	GO:0050714	positive regulation of protein secretion	Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
	GO:0045907	positive regulation of vasoconstriction	Any process that activates or increases the frequency, rate or extent of vasoconstriction.
	GO:0051258	protein polymerization	The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.
	GO:0051592	response to calcium ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0005938	cell cortex	The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:1903561	extracellular vesicle	Any vesicle that is part of the extracellular region.
	GO:0005577	fibrinogen complex	A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0031091	platelet alpha granule	A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
	GO:0031093	platelet alpha granule lumen	The volume enclosed by the membrane of the platelet alpha granule.

Chain C,F (FIBG_HUMAN | P02679)

molecular function
	GO:0050839	cell adhesion molecule binding	Interacting selectively and non-covalently with a cell adhesion molecule.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0030674	protein binding, bridging	The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
	GO:0005198	structural molecule activity	The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0072378	blood coagulation, fibrin clot formation	A protein activation cascade that contributes to blood coagulation and consists of the cascade of enzymatic reactions initiated by physical damage to the wall of a blood vessel, leading to the formation of a formation of a fibrin clot at the site of the injury. The process also includes numerous positive and negative regulatory events.
	GO:0007160	cell-matrix adhesion	The binding of a cell to the extracellular matrix via adhesion molecules.
	GO:0043623	cellular protein complex assembly	The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell.
	GO:0030198	extracellular matrix organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
	GO:0042730	fibrinolysis	A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:2000352	negative regulation of endothelial cell apoptotic process	Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
	GO:0031639	plasminogen activation	The process in which inactive plasminogen is processed to active plasmin. This process includes cleavage at an internal Arg-Val site to form an N-terminal A-chain and C-terminal B-chain held together by a disulfide bond, and can include further proteolytic cleavage events to remove the preactivation peptide.
	GO:0030168	platelet activation	A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
	GO:0070527	platelet aggregation	The adhesion of one platelet to one or more other platelets via adhesion molecules.
	GO:0002576	platelet degranulation	The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
	GO:0070374	positive regulation of ERK1 and ERK2 cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0045921	positive regulation of exocytosis	Any process that activates or increases the frequency, rate or extent of exocytosis.
	GO:0034116	positive regulation of heterotypic cell-cell adhesion	Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
	GO:0090277	positive regulation of peptide hormone secretion	Any process that increases the rate, frequency, or extent of the regulated release of a peptide hormone from secretory granules.
	GO:0050714	positive regulation of protein secretion	Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	Any process that activates or increases the frequency, rate or extent of substrate adhesion-dependent cell spreading.
	GO:0045907	positive regulation of vasoconstriction	Any process that activates or increases the frequency, rate or extent of vasoconstriction.
	GO:0051258	protein polymerization	The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein.
	GO:0009306	protein secretion	The controlled release of proteins from a cell.
	GO:0051592	response to calcium ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0005938	cell cortex	The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0009897	external side of plasma membrane	The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005577	fibrinogen complex	A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0031091	platelet alpha granule	A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG).
	GO:0031093	platelet alpha granule lumen	The volume enclosed by the membrane of the platelet alpha granule.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (0, 0)

Sites (0, 0)

SS Bonds (16, 16)

Cis Peptide Bonds (5, 5)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (31, 62)

PROSITE Motifs (2, 8)

Exons (13, 26)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (2, 10)

Gene Ontology (65, 151)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File